Drowsiness and Multiple sclerosis

Summary:

Multiple sclerosis is found among people with Drowsiness, especially for people who are female, 40-49 old.

The study analyzes which people have Multiple sclerosis with Drowsiness. It is created by eHealthMe based on reports of 52 people who have Drowsiness from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Drowsiness?

Drowsiness is found to be associated with 2,865 drugs and 4,797 conditions by eHealthMe. Check the latest studies of Drowsiness.

What is Multiple sclerosis?

Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,088 drugs and 1,359 conditions by eHealthMe. Check the latest studies of Multiple sclerosis.



On Jul, 19, 2026

52 people who have Drowsiness and Multiple Sclerosis are studied.

Would you have Multiple sclerosis when you have Drowsiness?

Gender of people who have Drowsiness and experienced Multiple Sclerosis *:

  • female: 82.69 %
  • male: 17.31 %

Age of people who have Drowsiness and experienced Multiple Sclerosis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 5.5600000000000005 %
  • 30-39: 33.33 %
  • 40-49: 33.33 %
  • 50-59: 16.67 %
  • 60+: 11.11 %

Common co-existing conditions for these people *:

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 23 people, 44.23%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 22 people, 42.31%
  3. Gait Disturbance: 6 people, 11.54%
  4. Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 5 people, 9.62%
  5. Fatigue (feeling of tiredness): 4 people, 7.69%
  6. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 5.77%
  7. Depression: 3 people, 5.77%
  8. High Blood Cholesterol: 3 people, 5.77%
  9. Affect Lability (emotional incontinence): 2 people, 3.85%
  10. Urinary Incontinence (inability to control the flow of urine and involuntary urination): 2 people, 3.85%

Common drugs taken by these people *:

  1. Xyrem: 27 people, 51.92%
  2. Adderall: 13 people, 25.00%
  3. Gabapentin: 11 people, 21.15%
  4. Nuvigil: 8 people, 15.38%
  5. Ibuprofen: 8 people, 15.38%
  6. Vitamins: 8 people, 15.38%
  7. Meloxicam: 8 people, 15.38%
  8. Baclofen: 8 people, 15.38%
  9. Ampyra: 8 people, 15.38%
  10. Cymbalta: 7 people, 13.46%

Common symptoms for these people *:

  1. Cardiac Disorder: 8 people, 15.38%
  2. Fatigue (feeling of tiredness): 8 people, 15.38%
  3. Insomnia (sleeplessness): 8 people, 15.38%
  4. Sleep Apnea Syndrome: 8 people, 15.38%
  5. Weight Decreased: 7 people, 13.46%
  6. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 7 people, 13.46%
  7. Weakness: 6 people, 11.54%
  8. Muscle Strain (an injury to a muscle in which the muscle fibres tear): 5 people, 9.62%
  9. Urinary Tract Infection: 5 people, 9.62%
  10. Cerebral Disorder (brain disease): 5 people, 9.62%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Multiple sclerosis?

- Check whether Multiple sclerosis is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Multiple sclerosis:

All the conditions that are associated with Multiple sclerosis:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Multiple sclerosis and Drowsiness, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: